Mental Health Institute & Faculty of Psychiatry of The Second Xiangya Hospital, Central South University
Welcome,         Profile    Billing    Logout  
 36 Trials 
42 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Li, Lingjiang
NCT04589143: A Double-blind, Placebo-controlled Study of Antidepressant Augmentation With Agomelatine

Completed
4
137
RoW
Agomelatine, Placebos
Central South University
Major Depressive Disorder
12/22
01/23
NCT04160377: A Clinical Trial of Fluvoxamine for Melancholia

Recruiting
2
150
RoW
Fluvoxamine, Fluvoxamine Maleate Tablets
Lingjiang Li
Depressive Disorder, Endogenous Depression, Melancholia
06/22
09/22
Zhang, Yan
NCT05291650: Ultrasound-guided Injection of Glucocorticoid Into Infrapatellar Fat Pad in Patients With Knee Osteoarthritis

Recruiting
4
60
RoW
Glucocorticoids, Saline, Hyaluronic acid
Zhujiang Hospital
Osteoarthritis, Knee
07/23
12/23
NCT04790305: Effect of Huaier Granule on Adjuvant Treatment for High-risk Early-stage Triple-negative Breast Cancer

Recruiting
4
1072
RoW
Huaier Granule, Z20000109(NMPA Approval Number)
Fudan University, LinkDoc Technology (Beijing) Co. Ltd., Huazhong University of Science and Technology
Carcinoma Breast, Triple-negative Breast Cancer, Invasive Ductal Carcinoma, Breast
12/27
07/28
ETER701, NCT04234607: A Study of TQB2450 or Placebo Combined With Anlotinib, Etoposide and Carboplatin Versus Etoposide and Carboplatin in Subjects With Extensive Small Cell Lung Cancer

Not yet recruiting
3
738
RoW
TQB2450, Anlotinib, Etoposide, Carboplatin, TQB2450(blank), Anlotinib(blank)
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Extensive Small Cell Lung Cancer
12/22
12/22
KRYSTAL-12, NCT04685135 / 2020-003645-11: Phase 3 Study of MRTX849 (Adagrasib) vs Docetaxel in Patients With Advanced Non-Small Cell Lung Cancer With KRAS G12C Mutation

Hourglass Jan 2023 - Jun 2023 : Completion of enrollment of KRYSTAL-12 trial for 2L NSCLC
Active, not recruiting
3
453
Europe, US, RoW
MRTX849, adagrasib, KRAZATI, Docetaxel, Taxotere
Mirati Therapeutics Inc.
Metastatic Non Small Cell Lung Cancer, Advanced Non Small Cell Lung Cancer
12/23
12/24
NCT05181137: A Phase 3 Study to Investigate the Efficacy and Safety of SHR0302 With Moderately to Severely Active Ulcerative Colitis

Recruiting
3
368
Europe, US, RoW
SHR0302, Placebo
Reistone Biopharma Company Limited
Ulcerative Colitis
10/24
03/25
SUNRAY-01, NCT06119581: A Study of LY3537982 Plus Immunotherapy With or Without Chemotherapy in Participants With Non-Small Cell Lung Cancer (NSCLC) With a Change in a Gene Called KRAS G12C

Recruiting
3
1016
Europe, Canada, Japan, US, RoW
LY3537982, Pembrolizumab, Placebo, Cisplatin, Carboplatin, Pemetrexed
Eli Lilly and Company, Loxo Oncology, Inc.
Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis
10/26
10/29
NCT02159820: Lower Dose Decitabine (DAC)-Primed TC (Carboplatin-Paclitaxel) Regimen in Ovary Cancer

Recruiting
2/3
500
RoW
Decitabine (DTC Arm), Paclitaxel and Carboplatin (TC Arm)
Chinese PLA General Hospital
Primary Malignant Neoplasm of Ovary, FIGO Stages II to IV
06/24
06/24
NCT03989336: An Open-label, Phase I/II Study of the Pan-immunotherapy in Patients With Relapsed/Refractory Ovarian Cancer

Completed
2
84
RoW
Manganese Chloride, nab-paclitaxel, Paclitaxel For Injection (Albumin Bound), Platinum chemotherapy, Sintilimab, anti-PD-1 antibody; PD-1 inhibitor
Chinese PLA General Hospital
Ovarian Cancer
05/22
12/23
NCT03250962: SHR-1210 Alone or in Combination With Decitabine in Relapsed or Refractory Hodgkin Lymphoma

Recruiting
2
280
RoW
SHR-1210, Decitabine
Chinese PLA General Hospital
Hodgkin Lymphoma
07/22
03/25
LEAD, NCT05092412: Low-dose Radiotherapy Combined With Durvalumab, Chemotherapy(EP) in the Treatment of ES-SCLC

Active, not recruiting
2
30
RoW
Low-dose radiotherapy, Durvalumab, Etoposide, and cisplatin/carboplatin
You Lu, AstraZeneca
Lung Cancer, Extensive-stage Small-cell Lung Cancer, Durvalumab
02/23
06/25
NCT06176729: Pola-R2 in Newly Diagnosed Non-fit Elderly DLBCL Patients

Recruiting
2
30
RoW
Polatuzumab Vedotin, Rituximab, Lenalidomide
Yan Zhang, MD, Peking University Third Hospital, Peking University First Hospital, Chinese PLA General Hospital
Diffuse Large B Cell Lymphoma
10/25
10/27
PUMCH-NHL-013, NCT05390749: Sequential Treatment With RO-MTX After Pomalidomide, Orelabrutinib, Rituximab (POR) in Newly-diagnosed PCNSL

Recruiting
2
50
RoW
Orelabrutinib, Pomalidomide, Rituximab, Methotrexate
Peking Union Medical College Hospital, Beijing Tiantan Hospital, Sanbo Brain Hospital Capital Medical University
Primary Central Nervous System Lymphoma
04/24
04/26
FOCUS-C, NCT05334277: Furmonertinib Monotherapy and Combination Therapy in Advanced EGFR Mutant NSCLC With Uncleared ctDNA

Recruiting
2
280
RoW
Furmonertinib, AST2818, Furmonertinib/Pemetrexed/Carboplatin, Furmonertinib/Pemetrexed/Carboplatin/Bevacizumab
Sun Yat-sen University, Allist Pharmaceuticals, Inc., GeneCast Biotechnology Co., Ltd.
Non-small Cell Lung Cancer
02/25
02/28
IMM01-04, NCT05833984: Safety and Efficacy of IMM01 Plus Tislelizumab in Patients With Advanced Solid Tumors and Lymphomas

Recruiting
1b/2
309
RoW
IMM01, SIRPα Fc, Tislelizumab
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
Solid Tumor, Classic Hodgkin Lymphoma
02/24
11/24
NCT03989310: An Open-label, Phase I/II Study of the Pan-immunotherapy in Patients With Local Advanced/Metastatic Pancreatic Cancer

Recruiting
1/2
50
RoW
Manganese Chloride, nab-paclitaxel, Paclitaxel For Injection (Albumin Bound), Gemcitabine, anti-PD-1 antibody, Anti-PD-1 monoclonal antibody; PD-1 inhibitor
Chinese PLA General Hospital
Pancreatic Cancer
05/21
03/22
NCT04588324: Study of SHR2150 (TLR7 Agonist) in Combination With Chemotherapy Plus PD-1 or CD47 Antibody in Subjects With Unresectable/ Metastatic Solid Tumors

Recruiting
1/2
50
RoW
SHR2150, Anti-Cancer Agent
Chinese PLA General Hospital
Solid Tumor
11/21
11/22
NCT04873440: An Open-label, Phase I/II Study of Manganese Plus Radiotherapy in Patients With Metastatic Solid Tumors or Lymphoma

Recruiting
1/2
10
RoW
Manganese Chloride, Mn2+, Radiotherapy, Chemo-immunotherapy
Chinese PLA General Hospital
Solid Tumor, Lymphoma
05/22
05/23
REMLA, NCT04120350: R2-MTX With Lenalidomide Maintenance in Newly-diagnosed PCNSL:a Multicenter Phase Ib/II Stuty

Recruiting
1/2
47
RoW
Methotrexate, Rituximab, Lenalidomide
Peking Union Medical College Hospital, Beijing Tiantan Hospital, Xuanwu Hospital, Beijing, Peking University Third Hospital, Beijing Hospital, Peking University First Hospital, Chinese PLA General Hospital
Primary Central Nervous System Lymphoma
08/22
08/24
NCT05867771: A Study of PM1022 in Patients With Advanced Tumors

Recruiting
1/2
200
RoW
PM1022
Biotheus Inc.
Advanced Tumors
04/24
04/25
NCT05416775: Phase Ib/II Study of SHR-8068 Injection in the Treatment of Advanced Non-small Cell Lung Cancer

Recruiting
1/2
168
RoW
SHR-8068;Adebrelimab, SHR-8068;adebrelimab and platinum-based chemotherapy, Adebrelimab;platinum-based chemotherapy
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Advanced Non-small Cell Lung Cancer
06/26
06/26
NCT05245916: IBI397 or Combination Therapies in Patients With Advanced Malignancies

Withdrawn
1a/1b
30
RoW
IBI397, IBI397+Sintilimab, IBI397+Rituximab
Innovent Biologics (Suzhou) Co. Ltd.
Advanced Malignancies
08/23
08/23
NCT06271928: A Multicenter Clinical Study of Yijing Keli in the Treatment of Ovarian Aging

Recruiting
1
100
RoW
Yijing Keli
Tongji Hospital
Ovarian Aging
01/24
01/25
NCT04487093: Clinical Study of Neoantigen Vaccine Combined With Targeted Drugs in the Treatment of Non-small Cell Lung Cancer

Recruiting
1
20
RoW
neoantigen vaccine + EGFR-TKI, neoantigen vaccine + anti-angioge
First Hospital of Shijiazhuang City, Tianjin Hengjia Biotechnology Development co., LTD
Non Small Cell Lung Cancer
05/22
12/22
NCT06256783: A Clinical Study of Baozhu Keli in the Treatment of Ovarian Aging

Recruiting
1
100
RoW
Baozhu Keli
Tongji Hospital
Ovarian Aging
01/24
01/25
NCT05114759: A Phase I Clinical Study of SHR-A2009 for Injection in Patients With Advanced Solid Tumors

Recruiting
1
132
Japan, RoW
SHR-A2009
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Advanced Solid Tumors
12/23
12/24
NCT05508334: A Study to Assess the Safety and Tolerability of RC88 for Patients With Advanced Solid Tumours

Recruiting
1
81
RoW
RC88, The injectable RC88
RemeGen Co., Ltd.
Advanced Solid Tumours
06/24
12/24
CS5001-101, NCT05279300: A Study of CS5001 in Patients With Advanced Solid Tumors and Lymphomas

Recruiting
1
156
US, RoW
CS5001
CStone Pharmaceuticals
Advanced Solid Tumor, Advanced Lymphoma
03/25
06/25
PE, NCT03542279: Immunotherapy in Autoimmune Encephalitis

Recruiting
N/A
70
RoW
Plasma exchange, IVIG, High-dose glucocorticoid
Yan Zhang
Autoimmune Encephalitis
12/21
12/23
NCT03703284: Molecular Mechanisms of Malignant Cerebral Edema After LHI

Recruiting
N/A
120
RoW
Treatments to reduce intracranial pressure
Xuanwu Hospital, Beijing
Cerebral Edema
12/22
06/23
UltraFuture I, NCT05498740: Post-marketing Study in Femoral Popliteal Artery of Drug Coated Balloon Used for Treatment of Lower Limb Ischemia

Recruiting
N/A
200
RoW
Drug eluting Balloon
Zhejiang Zylox Medical Device Co., Ltd.
Peripheral Arterial Disease (PAD)
12/22
12/24
NCT05447572: FIT Combining FC for Predicting MH and Histology Remission in UC

Recruiting
N/A
300
RoW
FIT + FC
Shandong University
Ulcerative Colitis, Histology Remission, Fecal Calprotetin, FIT, Mucosal Healing
12/22
12/23
NCT04361357: The Effects of Enteral Whey Protein Supplement on Serum Albumin Level in Acute Critically Ill Neurological Patients

Recruiting
N/A
116
RoW
whey protein
Xuanwu Hospital, Beijing
Nutrition Disorders, Neurologic Disorder
12/22
12/22
NCT05840861: Using 18F-FPEB PET to Identify mGLUR5 Availability in Affective Disorders

Recruiting
N/A
59
RoW
Vortioxetine, Quetiapine
Central South University
Major Depressive Disorder, Bipolar Disorder
08/23
09/23
DELTA, NCT05608655: DKutting Balloon Versus Chocolate Balloon to Treat Femoral and Popliteal Artery Stenosis

Completed
N/A
188
RoW
DKutting LL balloon, Chocolate balloon
DK Medical Technology (Suzhou) Co., Ltd.
Femoral Artery Stenosis, Popliteal Artery Stenosis
01/24
02/24
NCT06130319: Correlation of Disease Management and Quality of Life in Patients With Chronic Heart Failure and Their Family Caregivers

Recruiting
N/A
278
RoW
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Chronic Heart Failure
06/24
06/24
EVL, NCT06250803: Early Pancreatic Stent Placement for Preventing PEP

Not yet recruiting
N/A
768
RoW
early pancreatic stent placement (EPSP), late pancreatic stent placement (EPSP)
The First Affiliated Hospital of Anhui Medical University, First Affiliated Hospital Bengbu Medical College, Anqing Municipal Hospital, First Affiliated Hospital of Wannan Medical College, Tongcheng People's Hospital of Anhui province, Fuyang people's hospital
Cholangiopancreatography, Endoscopic Rretrograde, Post-ERCP Pancreatitis
03/26
03/26
NCT06452173: Risk Prediction Model for Cerebrovascular Events in Carotid Artery Stenosis

Enrolling by invitation
N/A
300
RoW
Plasma, carotid high-resolution magnetic resonance imaging
Beijing Tiantan Hospital, Beijing Neurosurgical Institute
Carotid Stenosis
10/26
12/26
NCT05454397: A Study on the Status of Nutritional Risk Screening and Nutritional Therapy in Neurology Hospitalized Stroke Patients

Recruiting
N/A
2000
RoW
Observational study, no intervention
Nanfang Hospital of Southern Medical University, First Affiliated Hospital of Fujian Medical University, Yantai Yuhuangding Hospital, The First Hospital of Jilin University, Qilu Hospital of Shandong University, ZHEJIANG PROVINCE XIAOSHAN HOSPITAL, The First People's Hospital of Wenling, Ganzhou People's Hospital, Affiliated Hospital of Jining Medical hospital, Henan Provincial People's Hospital, Zhongda Hospital Southeast University, The Second Affiliated Hospital of Harbin Medical University, The First people's Hospital of Kunshan, The 2nd Affiliated Hospital of Wenzhou Medical University, THE FIRST PEOPLE'S HOSPITAL OF JIASHAN, The First Affiliated Hospital of Xi'an Jiaotong University Medical College, Fujian Province Zhangzhou Hospital, People's Hospital of Chongqing, Nanjing Zijin Hospital, Hangzhou Red Cross Hospital, Wenzhou Hospital of Chinese Medicine, Kaifeng Central Hospital, First Affiliated Hospital of Guangxi Medical University, Zhongshan Hospital of Xiamen University, Xi'an Encephalopathy of Traditional Chinese Medicine Hospital, 903 Hospital of the Chinese People's Liberation Army Joint Logistics and Security Forces, Xiangya Hospital of Central South University, Second Affiliated Hospital of Suzhou University, Tongji Hospital, The Affiliated Hospital o fQingdao University, The First Affiliated Hospital of Anhui Medical University, Yancheng Third People's Hospital, Linyi People's Hospital, Dongfang Hospital of Beijing University of Chinese Medicine, Affiliated Hospital of Qingdao University
Acute Stroke
10/22
10/23
Li, Xueqin
NCT04160377: A Clinical Trial of Fluvoxamine for Melancholia

Recruiting
2
150
RoW
Fluvoxamine, Fluvoxamine Maleate Tablets
Lingjiang Li
Depressive Disorder, Endogenous Depression, Melancholia
06/22
09/22
EHCONSGDMC, NCT05911893: the Effect of High Caloric Oral Nutritional Supplements on Growth and Development of Malnourished Children

Not yet recruiting
N/A
800
RoW
high caloric oral nutritional supplements, high-energy total nutrition formula, nutritional education, dietary guidance
Children's Hospital of Chongqing Medical University, Anhui Provincial Children's Hospital, Baoji Maternity and Child Healthcare Hospital, Chengdu Women's and Children's Central Hospital, Guiyang Maternity and Child Health Care Hospital, Guangzhou Women and Children's Medical Center, Hunan Children's Hospital, Jiangxi Maternal and Child Health Hospital, Kunming Children's Hospital, Nanjing Maternity and Child Health Care Hospital, Children's Hospital of The Capital Institute of Pediatrics, Xianyang Children's Hospital, Nestle Health Science
Malnutrition, Child, Malnourishment, Nutritional Deficiency, Undernutrition
02/25
06/25
Yan, Danfeng
No trials found

Download Options